OPRX · Health Care

OptimizeRx Corporation earnings

Latest results: Q2 2026 reported Aug 14, 2026 OPRX +26.9% after the report

Shares surged 26.9% following Q2 results that beat revenue and adjusted EBITDA expectations, driven by ongoing margin expansion and strong commercial momentum in AI-enabled offerings and platform innovation.

  • Q2 revenue reached $20.5 million with adjusted EBITDA of $4.9 million, both surpassing consensus estimates.
  • Despite some revenue declines from a few large customers transitioning away from lower-margin services, growth was evident across the broader business.
  • AI-enabled software subscriptions grew 25% year-over-year, underscoring a successful shift toward recurring revenue models.

Next report: March 4, 2027 (estimated) · Earnings calendar

Every OPRX quarter

2 quarters, newest first, with how the stock moved after each report.

QuarterReportedStock afterWhat happened
Q2 2026 Aug 14, 2026 +26.9% Shares surged 26.9% following Q2 results that beat revenue and adjusted EBITDA expectations, driven by ongoing margin expansion and strong commercial momentum in AI-enabled offerings and platform innovation.
Q3 2025 Nov 7, 2025 Not available OptimizeRx reported a robust Q3 2025 with revenues of $26.1 million, reflecting a 22% year-over-year growth, and an adjusted EBITDA of $5.1 million, exceeding expectations.
Your portfolio

Track earnings for the stocks you own

Add your portfolio once, by connecting your broker or importing your history. When a company you hold reports, you get a recap like this one by email, with how the stock moved.